Yuliang Wang

2.5k total citations
100 papers, 1.6k citations indexed

About

Yuliang Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yuliang Wang has authored 100 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 27 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in Yuliang Wang's work include Prostate Cancer Treatment and Research (17 papers), Estrogen and related hormone effects (9 papers) and Epigenetics and DNA Methylation (8 papers). Yuliang Wang is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Estrogen and related hormone effects (9 papers) and Epigenetics and DNA Methylation (8 papers). Yuliang Wang collaborates with scholars based in China, Hong Kong and United States. Yuliang Wang's co-authors include Franky Leung Chan, Dinglan Wu, Zhu Wang, Shan Yu, Kexin Xu, Xiaoping Kang, Hao Hu, Yan-qun Na, Xiaofeng Wang and Chi‐Fai Ng and has published in prestigious journals such as Journal of Clinical Investigation, Nature Immunology and PLoS ONE.

In The Last Decade

Yuliang Wang

95 papers receiving 1.6k citations

Peers

Yuliang Wang
Yuliang Wang
Citations per year, relative to Yuliang Wang Yuliang Wang (= 1×) peers Danfeng Xu

Countries citing papers authored by Yuliang Wang

Since Specialization
Citations

This map shows the geographic impact of Yuliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuliang Wang more than expected).

Fields of papers citing papers by Yuliang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuliang Wang. The network helps show where Yuliang Wang may publish in the future.

Co-authorship network of co-authors of Yuliang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuliang Wang. A scholar is included among the top collaborators of Yuliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuliang Wang. Yuliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Jingyi, Yaojie Zhang, Yuxin Hou, et al.. (2025). Integrated metabolomic and transcriptomic analysis reveals the coordinated regulatory mechanisms of artemisinin and flavonoid mediated by AaMYB8 in Artemisia annua. International Journal of Biological Macromolecules. 330(Pt 2). 147998–147998.
3.
Sun, Shiqing, Hongbin Qiu, Kai Zhang, et al.. (2025). Antler base (Cervus nippon Temminck) peptides modulate the NLRP3 inflammatory pyroptosis and Nrf2/HO-1/NQO1 signaling pathways to ameliorate osteoarthritis: a structural and mechanistic study. Journal of Ethnopharmacology. 351. 120149–120149. 1 indexed citations
4.
Xue, Chen, Kai Zhang, Shiqing Sun, et al.. (2025). Structural Characterization and Anti-Gouty Nephropathy Potential of Polysaccharides from Atractylodes chinensis. Molecules. 30(4). 757–757. 3 indexed citations
5.
Wang, Yuliang, Peng Xu, Hao Song, et al.. (2024). Revitalizing Bacillus Calmette–Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches. Pharmaceutics. 16(8). 1067–1067. 2 indexed citations
6.
Li, Xiao, Xiaopei Hao, Yuliang Wang, et al.. (2024). GJB2 Promotes HCC Progression by Activating Glycolysis Through Cytoplasmic Translocation and Generating a Suppressive Tumor Microenvironment Based on Single Cell RNA Sequencing. Advanced Science. 11(39). e2402115–e2402115. 10 indexed citations
7.
Rong, Dawei, Yuliang Wang, Li Liu, et al.. (2023). GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway. Journal for ImmunoTherapy of Cancer. 11(2). e005126–e005126. 17 indexed citations
8.
Sun, Guangshun, Yuliang Wang, Hanyuan Liu, et al.. (2023). CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening. Journal of Experimental & Clinical Cancer Research. 42(1). 248–248. 35 indexed citations
9.
Liu, Pengyu, Wenxuan Wang, Fei Wang, et al.. (2023). Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. Journal of Translational Medicine. 21(1). 40–40. 32 indexed citations
10.
Liu, Xiaohui, et al.. (2023). Intrarenal pressure study using 7.5 French flexible ureteroscope with or without ureteral access sheath in an ex-vivo porcine kidney model. World Journal of Urology. 41(11). 3129–3134. 5 indexed citations
11.
Yin, Yuye, Xinyi Yang, Shusheng Wu, et al.. (2022). Jmjd1c demethylates STAT3 to restrain plasma cell differentiation and rheumatoid arthritis. Nature Immunology. 23(9). 1342–1354. 37 indexed citations
12.
Zhang, Le, Yuye Yin, Jun Wang, et al.. (2022). Histone methyltransferase Nsd2 ensures maternal–fetal immune tolerance by promoting regulatory T-cell recruitment. Cellular and Molecular Immunology. 19(5). 634–643. 14 indexed citations
13.
Levy, Shiri, Ashish Phal, Sven Schmidt, et al.. (2022). dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region. Cell Reports. 38(9). 110457–110457. 14 indexed citations
14.
Yang, Wei, He Xue, Yuying Yao, et al.. (2022). Genome-Wide Association Study on the Hematological Phenotypic Characteristics of the Han Population from Northwest China. Pharmacogenomics and Personalized Medicine. Volume 15. 743–763. 2 indexed citations
15.
Hu, Bo, Ge Wen, Yuliang Wang, et al.. (2021). Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation. Frontiers in Genetics. 12. 789485–789485. 8 indexed citations
16.
Wang, Yuliang, Kexin Xu, Hao Hu, et al.. (2018). Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis. Cancer Research. 78(9). 2205–2218. 38 indexed citations
17.
Guo, Dong, et al.. (2018). Prediction of the Risk of Laparoscopy-Assisted Gastrectomy by Comparing Visceral Fat Area and Body Mass Index. Gastroenterology Research and Practice. 2018. 1–7. 15 indexed citations
18.
Yang, Yang, et al.. (2015). [Yearly Changes of Phytoplankton Community in the Ecology-monitoring Area of Changli, Hebei in Summer].. PubMed. 36(4). 1317–25. 4 indexed citations
19.
Lin, Lin, et al.. (2012). Effect of light rhythm on the expression of cryptochrom 2 in retina. Zhonghua shiyan yanke zazhi. 30(11). 994–998. 1 indexed citations
20.
Wang, Yuliang. (2006). Epimorphin-/- mice have increased intestinal growth, decreased susceptibility to dextran sodium sulfate colitis, and impaired spermatogenesis. Journal of Clinical Investigation. 116(6). 1535–1546. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026